-+ 0.00%
-+ 0.00%
-+ 0.00%

Simris Group Appoints András Strassz as Chief Medical Officer

PUBT·10/29/2026 08:34:02
Simris Group Appoints András Strassz as Chief Medical Officer
  • Simris Group appointed András Strassz as chief medical officer to lead clinical development of its antibody-drug conjugate programs.
  • Strassz previously served as Heidelberg Pharma’s chief medical officer, where he built the clinical development function.
  • He brings more than 20 years of pharmaceutical and biotechnology experience across oncology, hematology and immunology.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simris Group AB published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.